Welcome to Targeting Phage Therapy


The 7th World Conference on Targeting Phage Therapy is being organized on June 20-21, 2024 at Corinthia Palace Malta.

We invite you to the Phage Therapy 2024 Conference, a two-day event focused on the latest in phage research, current challenges, and future directions. This conference will bring together experts, researchers, and healthcare professionals to discuss phage therapy and its application in medicine. 

Keynote Speech 2024: Prof. Robert T. Schooley

It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2024, this June in Malta.
 
He will present a talk on: Phage Therapeutics 2024: Essential Translational Research Components for Clinical Trials. Read More

Save the Dates

Among the speakers

Who Attended Targeting Phage Therapy 2023?

Industrial participants:

PHIOGEN (USA)
Armata Pharmaceuticals (USA)

BiomX (Israel)
Acteryon (Poland)
Cellexus (UK)
Adaptive Phage Therapeutics (USA)
Aparon (UK)
AusHealth (Australia)
Biochimpharm JSC (Georgia)
BIOCODEX (Paris)
BIOMERIEUX SA (France)
COBIK (Slovenia)
ERYTECH Pharma (France)
H Venture Partners (USA)
H Ventures (USA)
Intralytix, Inc. (USA)
Jafral (Slovenia)
MB Pharma s.r.o. (Czech Republic)
Microbiotix Inc. (USA)
Optipharm Inc. (Republic of Korea)
Phage Consulting
Phages2Patients (Germany)
Phagos (France)
Pherecydes Pharma (France)
Proteon Pharmaceuticals S.A. (Poland)
R.E.D. Laboratories (Belgium)
Resistell (Switzerland)
Rime Bioinformatics (France)
Sanofi (USA)
SET Medikal (Turkey)
TechnoPhage (Poland)
Tillotts Pharma AG (Switzerland)
Vésale Bioscience (Belgium)
Vetoquinol (France)
Vitalis Phage Therapy (India)

Academic participants:

Adam Mickiewicz University, Agricultural University of Athens, Amrita Universit, Armata Therapeutics, Azabu University, Bacteriophage.news, Baylor College of Medicine, Bhabha Atomic Research Centre, Biological Research Centre, Szeged, Campus Universitaire de Maubeuge, Centre International de Recherche en Infectiologie, Chungnam Natl. Univ., Comenius University, Communicable Diseases Institute, Consejo Superior de Investigaciones Científicas, Corpo De Bombeiros Militar Do Amazonas,Corpo De Bombeiros Militar Do Amazonas / Fundação Universidade Aberta Da Terceira Idade, CY Paris Cergy Université, Department of Veterinary Medicine, Institute of Pharmacology and Toxicology, Free University Berlin, Deutsches Zentrum für Infektionsforschung, ENS de Lyon, Eötvös Loránd University, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Food and Drug Administration (FDA), Fundação Universidade Aberta Da Terceira, Fundación AZTI, G. Eliava Institute of Bacteriophages, microbiology and virology ,Geneva University Hospital, German Center for Infection Research (DZIF),German Federal Institute for Risk Assessment, Helmholtz Center Munich, Hirszfeld Institute of Immunology and Experimental Therapy, Hôpitaux Unversitaires de Genève,Hospices Civils de Lyon, Ilia State University, INSERM, Institut Pasteur, Instituto de Biología Integrativa de Sistemas (I2SysBio) Universitat de València-CSIC, Israel Institute for Biological Research,Istanbul University, Istinye University, Jomo Kenyatta University of Agriculture and Technology, Khon Kaen University, Korea Advanced Institute of Science and Technology, KU Leuven, Kyorin University, Laboratoire ERRMECe, Laboratoire M2iSH, Lesaffre International, Louvain University, Masaryk University, Max Planck Institute for Medical Research, Medical center Francesc Macia, MPI, National Taiwan University, North-West Unversity, Pediatric Infectious Diseases Research Center, Phage Consulting, Phage Directory, Pharmabiotic Research Institute (PRI), Polish Academy of Sciences…

Read more

Upcoming Events